Newsbenzinga
Cardiol Therapeutics Announces Over $7M In Proceeds From Warrant Exercises, Extending Cash Runway Into H1 2028; Issues Acceleration Notice On 425,000 Remaining Warrants, Expiring October 16
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…